Emetrol Powder

Manufacturer
WellSpring Pharmaceutical Corporation
Effective date
2025-01-08
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
full-release
Hydrated at
2026-06-01 00:51:31

Label at a glance#

ProductEmetrol Powder Non-Drowsy
Active ingredientTRISODIUM CITRATE DIHYDRATE
Label structure10 sections

Indications and uses

For the relief of nausea associated with upset stomach, including that due to overindulgence in food and drink.

Dosage and administration

Adults: 1-2 packets 3 to 4 times a day. Children: Consult a doctor for appropriate dosage. Dosage may be repeated after 15 minutes, not to exceed 4 packets in a 24-hour period unless advised by a doctor. Dissolve contents of one (1) packet in 4 oz. of room temperature water before consumption. Stir again if needed Read all package directions and warnings before use and use only as directed.

Label contents#

Full prescribing information#

Active ingredients (in each packet)

OTC - ACTIVE INGREDIENT SECTION

  • Sodium citrate dihydrate USP 460 mg

Purpose

OTC - PURPOSE SECTION

Upset stomach reliever

Uses

INDICATIONS & USAGE SECTION

For the relief of nausea associated with upset stomach, including that due to overindulgence in food and drink.

Warnings

WARNINGS SECTION

Ask a doctor before use if you 

OTC - ASK DOCTOR SECTION

  • have diabetes because this product contains sugar
  • are on a sodium-restricted diet

Ask a doctor or pharmacist before use if

SPL UNCLASSIFIED SECTION

  • you are taking any other medications. This product may interact with certain prescription drugs.

When using this product,

SPL UNCLASSIFIED SECTION

  • do not take more than 4 packets in a 24-hour period.

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • nausea lasts more than two weeks or recurs frequently.

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

  • ask a health professional before use.

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Adults: 1-2 packets 3 to 4 times a day.
  • Children: Consult a doctor for appropriate dosage.
  • Dosage may be repeated after 15 minutes, not to exceed 4 packets in a 24-hour period unless advised by a doctor.
  • Dissolve contents of one (1) packet in 4 oz. of room temperature water before consumption. Stir again if needed
  • Read all package directions and warnings before use and use only as directed.

Other information

SPL UNCLASSIFIED SECTION

  • Each table contains: Sodium 110 mg/8 g
  • Store at room temperature
  • Protect product from excessive heat, cold and moisture.
  • Note: This product is not intended as a substitute for a balanced nutritional diet or as an electrolyte replenishment.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Citric acid anhydrous, natural & artificial lemon flavor, silica, sucralose, sucrose.

Questions or Comments?

SPL UNCLASSIFIED SECTION

1-844-241-5454 or Emetrol.com 

Distributed By

SPL UNCLASSIFIED SECTION

WellSpring Pharmaceutical Corporation
Sarasota, FL 34243
(c) 2023 WellSpring Pharmaceutical Corporation

PACKAGE LABEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

PHARMACIST RECOMMENDED

NDC# 65197-203-09

New

Non-Drowsy

Emetrol POWDER

Rapid Nausea Relief

  • Treats the source of Nausea*
  • Dissolve Faster in your Stomach
  • Great Tasting Lemon Flavor
  • Specially Formulated for Adults

*Due to overindulgence in food and drink

FSA/HAS Eligible

lemon flavor

6 PACKAETS

Emetrol non-drowsy rapid Nausea Relief 6 packets lemon flavor
Emetrol non-drowsy rapid Nausea Relief 6 packets lemon flavor

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
2671579Emetrol Powder 460 MG Powder for Oral SolutionPSN3
2671573sodium citrate 460 MG Powder for Oral SolutionPSN3
2671579sodium citrate 460 MG Powder for Oral Solution [Emetrol Powder]SBD3
2671573sodium citrate 460 MG Powder for Oral SolutionSCD3
2671579Emetrol Powder 460 MG Powder for Oral SolutionSY3
2671573sodium citrate 460 MG Powder for Oral SolutionSY3

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
ANHYDROUS CITRIC ACID Pharmacologic Class Indexing3Indexing - Pharmacologic Class20180813

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
65197-203-09Emetrol PowderNon-Drowsy6 in 1 CARTONPOWDER, FOR SOLUTION63

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
65197-203EMETROL POWDER NON-DROWSY (SODIUM CITRATE DIHYDRATE) POWDER, FOR SOLUTION [WELLSPRING PHARMACEUTICAL CORPORATION]3Current NDC, 1 package rows20250110_9d8d2ee7-9db7-4be7-8c73-511eb2e32459.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
65197-20365197-203-09

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Emetrol Powder Non-DrowsySODIUM CITRATE DIHYDRATEWellSpring Pharmaceutical Corporation9d8d2ee7-9db7-4be7-8c73-511eb2e324592025-01-08WarningsExact identifier
ndc (package): 65197-203-09
ndc (product): 65197-203
ndc11 (package): 65197020309
spl id: a6121b17-e850-4677-9ad1-ceb36de16336
spl set id: 9d8d2ee7-9db7-4be7-8c73-511eb2e32459

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.